跳至主要内容
临床试验/NCT03363100
NCT03363100已完成不适用

Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c

Evidation Health2 个研究点 分布在 1 个国家目标入组 624 人开始时间: 2017年12月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
624
试验地点
2
主要终点
A1c

研究概览

简要总结

The Diabetes Coaching Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Health Partnership on A1c levels for individuals with uncontrolled Type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Humana Medicare Advantage member
  • Type 2 diabetes diagnosis
  • HbA1c levels ≥ 8.0% verified by lab test

排除标准

  • Has any of the following conditions: cancer, chronic heart failure, chronic obstructive pulmonary disease, respiratory failure, chronic kidney disease, end stage renal disease, peripheral vascular disease
  • Not fluent in English
  • Humana membership is part of a Full or Global risk arrangement
  • Enrolled in Humana at Home Care Management

研究组 & 干预措施

Control

No Intervention

Intervention

Experimental

干预措施: Digital health Partnership program (Behavioral)

结局指标

主要结局

A1c

时间窗: Baseline and 6 months

Change in A1c from study baseline to study end for participants

次要结局

未报告次要终点

研究者

发起方
Evidation Health
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验